ask="16.83"
ask_size="400"
average_daily_volume="678124"
bid="14.00"
bid_size="100"
book_value="9.23"
change="-0.74"
change_from_200_day_moving_average="-12.26"
change_from_50_day_moving_average="-1.33"
change_from_52_week_high="-32.99"
change_From_52_week_low="3.39"
change_in_percent="-4.96%"
close="14.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.73"
ebitda="-119.41M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-3.28"
ex_dividend_date="N/A"
float_shares="33671000"
high="14.99"
high_52_weeks="47.18"
last_trade_date="1/17/2017"
last_trade_price="14.19"
last_trade_size="22777"
last_trade_time="4:00pm"
low="14.16"
low_52_weeks="10.80"
market_capitalization="613.97M"
moving_average_200_day="26.45"
moving_average_50_day="15.52"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="35.63"
open="14.79"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-46.34%"
percent_change_from_50_day_moving_average="-8.56%"
percent_change_from_52_week_high="-69.92%"
percent_change_from_52_week_low="+31.39%"
previous_close="14.93"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.62"
price_per_sales="2451.90"
revenue="263466.00"
shares_outstanding="43268000"
short_ratio="6.89"
stock_exchange="NMS"
symbol="ITCI"
volume="408151"
weeks_range_52="10.80 - 47.18"
